Group One Trading, L.P. Vivos Therapeutics, Inc. Transaction History

Group One Trading, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$0.31 - $0.55 $339 - $602	-1,095 Reduced 83.72%	213 $0
Q1 2023 May 12, 2023	SELL	$0.32 - $1.88 $733 - $4,308	-2,292 Reduced 63.67%	1,308 $0
Q4 2022 Feb 09, 2023	SELL	$0.35 - $20.75 $3,935 - $233,313	-11,244 Reduced 75.75%	3,600 $1,000
Q3 2022 Nov 09, 2022	SELL	$0.83 - $21.25 $9,593 - $245,628	-11,559 Reduced 43.78%	14,844 $10,000
Q2 2022 Aug 11, 2022	SELL	$1.12 - $2.18 $45,623 - $88,802	-40,735 Reduced 60.67%	26,403 $34,000
Q1 2022 May 12, 2022	BUY	$1.63 - $3.63 $101,997 - $227,147	62,575 Added 1371.36%	67,138 $180,000
Q4 2021 Feb 11, 2022	SELL	$2.25 - $4.11 $6,239 - $11,397	-2,773 Reduced 37.8%	4,563 $10,000
Q3 2021 Nov 12, 2021	BUY	$2.71 - $5.9 $19,880 - $43,282	7,336 New	7,336 $30,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.